$2.47T
Total marketcap
$65.92B
Total volume
BTC 50.74%     ETH 15.10%
Dominance

Awakn Life Sciences AWKNF Stock

0.14 USD {{ price }} -15.624994% {{change_pct}}%
Exchange
Other OTC
Market Cap
5.23M USD
LOW - HIGH [24H]
0.1 - 0.15 USD
VOLUME [24H]
32.41K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.2 USD

Awakn Life Sciences Price Chart

Awakn Life Sciences AWKNF Financial and Trading Overview

Awakn Life Sciences stock price 0.14 USD
Previous Close 0.17 USD
Open 0.21 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.14 - 0.21 USD
52 Week Range 0.09 - 0.72 USD
Volume 29.41K USD
Avg. Volume 18.93K USD
Market Cap 5.85M USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.2 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 9.95 USD

AWKNF Valuation Measures

Enterprise Value 6.4M USD
Trailing P/E N/A
Forward P/E -0.6958333
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 3.338098
Price/Book (mrq) N/A
Enterprise Value/Revenue 3.653
Enterprise Value/EBITDA -0.794

Trading Information

Awakn Life Sciences Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -68.38%
S&P500 52-Week Change 20.43%
52 Week High 0.72 USD
52 Week Low 0.09 USD
50-Day Moving Average 0.22 USD
200-Day Moving Average 0.28 USD

AWKNF Share Statistics

Avg. Volume (3 month) 18.93K USD
Avg. Daily Volume (10-Days) 32K USD
Shares Outstanding 35.04M
Float 19.29M
Short Ratio N/A
% Held by Insiders 1.91%
% Held by Institutions 8.34%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends January 31, 2023
Most Recent Quarter (mrq) April 30, 2023
Next Fiscal Year End January 31, 2024

Profitability

Profit Margin 0%
Operating Margin (ttm) -484.65%
Gross Margin -94.13%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -87.31%
Return on Equity (ttm) -597.57%

Income Statement

Revenue (ttm) 1.75M USD
Revenue Per Share (ttm) 0.07 USD
Quarterly Revenue Growth (yoy) 101.79%
Gross Profit (ttm) N/A
EBITDA -8067242 USD
Net Income Avi to Common (ttm) -8014349 USD
Diluted EPS (ttm) -0.3
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 389.7K USD
Total Cash Per Share (mrq) 0.02 USD
Total Debt (mrq) 2.48M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.261
Book Value Per Share (mrq) -0.029

Cash Flow Statement

Operating Cash Flow (ttm) -6130310 USD
Levered Free Cash Flow (ttm) -3683961 USD

Profile of Awakn Life Sciences

Country United States
State ON
City Toronto
Address 301-217 Queen Street West
ZIP M5V 0R2
Phone N/A
Website https://awaknlifesciences.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 44

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.

Q&A For Awakn Life Sciences Stock

What is a current AWKNF stock price?

Awakn Life Sciences AWKNF stock price today per share is 0.14 USD.

How to purchase Awakn Life Sciences stock?

You can buy AWKNF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Awakn Life Sciences?

The stock symbol or ticker of Awakn Life Sciences is AWKNF.

Which industry does the Awakn Life Sciences company belong to?

The Awakn Life Sciences industry is Biotechnology.

How many shares does Awakn Life Sciences have in circulation?

The max supply of Awakn Life Sciences shares is 38.73M.

What is Awakn Life Sciences Price to Earnings Ratio (PE Ratio)?

Awakn Life Sciences PE Ratio is now.

What was Awakn Life Sciences earnings per share over the trailing 12 months (TTM)?

Awakn Life Sciences EPS is -0.2 USD over the trailing 12 months.

Which sector does the Awakn Life Sciences company belong to?

The Awakn Life Sciences sector is Healthcare.